Endostar combined with intensity-modulated radiotherapy in low-risk local advanced nasopharyngeal carcinoma: A phase II, randomized, multicentric clinical trial.

Min Kang,Shaomin Lin,Haisheng Zhu,Sihui Liao,Haixin Huang,Bin Yu,Hongqian Wang,Meilian Liu,Jinxian Zhu,Guang Huang,Tingting Zhang,Zhendong Yang,Pingting Zhou,Ziyan Zhou,Yu-Tao Qin,Zhuxin Wei,Qinghua Du,Changhong Zhao,Mingjun Shen,Rensheng Wang

Endostar combined with intensity-modulated radiotherapy in low-risk local advanced nasopharyngeal carcinoma: A phase II, randomized, multicentric clinical trial.

2021

6050Background: A Phase II, randomized, prospective, multicentric trial was conducted to evaluate the efficacy and safety of Endostar plus radiotherapy in patients with low-risk local advanced naso...

Keywords:

intensity modulated radiotherapy
Nasopharyngeal carcinoma
in patient
Radiology
Medicine
Clinical trial
Radiation therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations